相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。UGT2B7 promoter variant-840G>A contributes to the variability in hepatic clearance of morphine in patients with sickle cell disease
Deepika S. Darbari et al.
AMERICAN JOURNAL OF HEMATOLOGY (2008)
No influence of ABCB1 haplotypes on methadone dosage requirement
S. Crettol et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Lack of Interaction of the NMDA Receptor Antagonists Dextromethorphan and Dextrorphan with P-Glycoprotein
Jules Desmeules et al.
CURRENT DRUG METABOLISM (2008)
Effects of the CYP2D6 gene duplication on the pharmacokinetics and pharmacodynamics of tramadol
Julia Kirchheiner et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief
D. Campa et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects
Magnus Ingelman-Sundberg et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Selective induction of human hepatic cytochromes P4502B6 and 3A4 by metamizole
T. Saussele et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Oxycodone induces overexpression of p-glycoprotein (ABCB1) and affects paclitaxel's tissue distribution in Sprague Dawley rats
Hazem E. Hassan et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: Role of cytochrome P4502C9 polymorphisms
Alberto Pilotto et al.
GASTROENTEROLOGY (2007)
Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication
J. Kirchheiner et al.
PHARMACOGENOMICS JOURNAL (2007)
UGT1A6 polymorphism and salicylic acid glucuronidation following aspirin
Yu Chen et al.
PHARMACOGENETICS AND GENOMICS (2007)
Association of CYP2D6 ultrarapid metabolizer genotype with deficient patient satisfaction regarding methadone maintenance treatment
Jose Perez de los Cobos et al.
DRUG AND ALCOHOL DEPENDENCE (2007)
Polymorphic CYP2B6:: molecular mechanisms and emerging clinical significance
Ulrich M. Zanger et al.
PHARMACOGENOMICS (2007)
Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes
U. M. Stamer et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain:: OPRM1 and COMT gene
Cielito C. Reyes-Gibby et al.
PAIN (2007)
Predominant contribution of UDP-glucuronosyltransferase 2B7 in the glucuronidation of racemic flurbiprofen in the human liver
Yuji Mano et al.
DRUG METABOLISM AND DISPOSITION (2007)
Sex-dependent genetic markers of CYP3A4 expression and activity in human liver microsomes
Markus Schirmer et al.
PHARMACOGENOMICS (2007)
Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizers
C. B. Eap et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology
Georg B. Ehret et al.
EXPERT OPINION ON DRUG SAFETY (2007)
Genetic Polymorphisms in the ABCB1 gene and the effects of fentanyl in Koreans
H-J Park et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Use of plasma and brain unbound fractions to assess the extent of brain distribution of 34 drugs: Comparison of unbound concentration ratios to in vivo P-glycoprotein efflux ratios
J. Cory Kalvass et al.
DRUG METABOLISM AND DISPOSITION (2007)
Contribution of UDP-glucuronosyltransferases 1A9 and 2B7 to the glucuronidation of indomethacin in the human liver
Yuji Mano et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Pharmacokinetics and pharmacodynamics of alfentanil in P-glycoprotein-competent and P-glycoprotein-deficient mice: P-glycoprotein efflux alters alfentanil brain disposition and antinociception
J. Cory Kalvass et al.
DRUG METABOLISM AND DISPOSITION (2007)
Inhibitory potential of nonsteroidal anti-inflammatory drugs on UDP-glucuronosyltransferase 2B7 in human liver microsomes
Yuji Mano et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Identification and functional characterization of polymorphisms in human cyclooxygenase-1 (PTGS1)
Craig R. Lee et al.
PHARMACOGENETICS AND GENOMICS (2007)
The emerging importance of transporter proteins in the psychopharmacological treatment of the pregnant patient
Jun-Sheng Wang et al.
DRUG METABOLISM REVIEWS (2007)
Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2/ABCC2-and MRP4/ABCC4-mediated methotrexate transport
Azza A. K. El-Sheikh et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Genetic susceptibility to diclofenac-induced hepatotoxicity: Contribution of UGT2B7, CYP2C8, and ABCC2 genotypes
Ann K. Daly et al.
GASTROENTEROLOGY (2007)
Effects of combined UDP-glucuronosyltransferase (UGT) 1A1*28 and 1A6*2 on paracetamol pharmacokinetics in beta-thalassemia/HbE
Jeeranut Tankanitlert et al.
PHARMACOLOGY (2007)
Pharmacokinetics of tramadol is affected by MDR1 polymorphism C3435T
Ondrej Slanar et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Increased (R)-methadone plasma concentrations by quetiapine in cytochrome P450s and ABCB1 genotyped patients
Claude Uehlinger et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2007)
The cyclooxygenase 2 genetic variant-765G>C does not modulate the effects of celecoxib on prostaglandin E2 production
Carsten Skarke et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
ABCB1 and cytochrome P450 genotypes and phenotypes:: Influence on methadone plasma levels and response to treatment
Severine Crettol et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals
Janet K. Coller et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Effect of the CYP2D6*10 C188T polymorphism on postoperative tramadol analgesia in a Chinese population
GuoXiang Wang et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Allele variants of the cytochrome P4502C9 genotype in white subjects from the Netherlands with serious gastroduodenal ulcers attributable to the use of NSAIDs
Harald E. Vonkeman et al.
CLINICAL THERAPEUTICS (2006)
Identification of human UDP-glucuronosyltransferase isoform(s) responsible for the C-glucuronidation of phenylbutazone
Takahito Nishiyama et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2006)
Inhibition of human phenol and estrogen sulfotransferase by certain non-steroidal anti-inflammatory agents
Roberta S. King et al.
CURRENT DRUG METABOLISM (2006)
Response to hydrocodone, codeine and oxycodone in a CYP2D6 poor metabolizer
Margaret T. Susce et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
Mu opioid receptor-dependent and independent components in effects of tramadol
Soichiro Ide et al.
NEUROPHARMACOLOGY (2006)
The μ-opioid receptor gene polymorphism 118A > G depletes alfentanil-induced analgesia and protects against respiratory depression in homozygous carries
Bruno G. Oertel et al.
PHARMACOGENETICS AND GENOMICS (2006)
Association of μ-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty
W. -Y. Chou et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2006)
Human opioid receptor A118G polymorphlism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy
Wen-Ying Chou et al.
ANESTHESIOLOGY (2006)
Interactions between CYP2C9 and UGT1A6 polymorphisms and nonsteroidal anti-inflammatory drugs in colorectal cancer prevention
Wade S. Samowitz et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Identification of human UDP-glucuronosyltransferase responsible for the glucuronidation of niflumic acid in human liver
Yuji Mano et al.
PHARMACEUTICAL RESEARCH (2006)
Sulfotransferase (SULT) 1A1 polymorphic variants*1,*2, and*3 are associated with altered enzymatic activity, cellular phenotype, and protein degradation
Swati Nagar et al.
MOLECULAR PHARMACOLOGY (2006)
Genetically mediated interindividual variation in analgesic responses to cyclooxygenase inhibitory drugs
Yun-Sil Lee et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: Role of circulating active metabolites
Bojan Lalovic et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Environmental and genetic factors associated with morphine response in the postoperative period
L Coulbault et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Implications of genetic polymorphisms in drug transporters for pharmacotherapy
R Kerb
CANCER LETTERS (2006)
Accumulation of celecoxib with a 7-fold higher drug exposure in individuals homozygous for CYP2C9*3
MS Lundblad et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Determinant role of CYP2D6 and CYP3A4 pathways on the antinociceptive effects of oxycodone.
C Samer et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Correlation of CYP2D6 genotype with response to oxycodone in orthopedic injury related pain.
AB Myers et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Glucuronidation of the aspirin metabolite salicylic acid by expressed UDP-glucuronosyltransferases and human liver microsomes
GE Kuehl et al.
DRUG METABOLISM AND DISPOSITION (2006)
The analgesic efficacy of partial oploid agonists is increased in mice with targeted inactivation of the α2A-adrenoceptor gene
ÜK Özdogan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
A common novel CTP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants
SC Sim et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Evidence for morphine-independent central nervous opioid effects after administration of codeine: Contribution of other codeine metabolites
J Lotsch et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Modulation of the central nervous effects of levomethadone by genetic polymorphisms potentially affecting its metabolism, distribution, and drug action
J Lotsch et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Is celecoxib an inducer of cytochrome P450 3A4 in subjects carrying the CYP2C9*3 allele?
A. David Rodrigues et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
In vitro inhibitory effects of non-steroidal anti-inflammatory drugs on 4-methylumbelliferone glucuronidation in recombinant human UDP-glucuronosyltransferase 1A9-potent inhibition by niflumic acid
Y Mano et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2006)
Significance of the minor cytochrome P450 3A isoforms
AK Daly
CLINICAL PHARMACOKINETICS (2006)
Possible fluconazole-fentanyl interaction - a case report
Par Hallberg et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Human white blood cells synthesize morphine: CYP2D6 modulation
W Zhu et al.
JOURNAL OF IMMUNOLOGY (2005)
Polymorphisms in genes encoding acetylsalicylic acid metabolizing enzymes are unrelated to upper gastrointestinal health in cardiovascular patients on acetylsalicylic acid
MGH van Oijen et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment
S Crettol et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Pharmacogenetics/genomics and personalized medicine
W Sadée et al.
HUMAN MOLECULAR GENETICS (2005)
COMT Val108/158 Met genotype affects the mu-opioid receptor system in the human brain:: Evidence from ligand-binding, G-protein activation and preproenkephalin mRNA expression
A Berthele et al.
NEUROIMAGE (2005)
Genetic polymorphism and drug interactions: their importance in the treatment of pain
CF Samer et al.
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE (2005)
Influence of CYP2C9 genotypes on the pharmacokinetics and pharmacodynamics of piroxicam
JA Perini et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Phenobarbital and phenytoin increased acetaminophen hepatotoxicity due to inhibition of UDP-glucuronosyltransferases in cultured human hepatocytes
SE Kostrubsky et al.
TOXICOLOGICAL SCIENCES (2005)
Genetic variability and clinical efficacy of morphine
P Klepstad et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2005)
The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients
TT Rakvåg et al.
PAIN (2005)
Melanocortin-1 receptor gene variants affect pain and μ-opioid analgesia in mice and humans
JS Mogil et al.
JOURNAL OF MEDICAL GENETICS (2005)
Role of CYP2C9 and its variants (CYP2C9*3 and CYP2C9*13) in the metabolism of lornoxicam in humans
YJ Guo et al.
DRUG METABOLISM AND DISPOSITION (2005)
Oxycodone pharmacokinetics and pharmacodynamics in the rat in the presence of the P-glycoprotein inhibitor PSC833
E Boström et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Cytochrome P4502C8: Substrates, inhibitors, pharmacogenetics, and clinical relevance
RA Totah et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Inhibition of human intestinal wall metabolism by macrolide antibiotics: Effect of clarithromycin on cytochrome P450 3A4/5 activity and expression
AG Pinto et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Increased sensitivity to thermal pain and reduced subcutaneous lidocaine efficacy in redheads
EB Liem et al.
ANESTHESIOLOGY (2005)
In vitro inhibitory effects of non-steroidal antiinflammatory drugs on UDP-glucuronosyltransferase 1A1-catalysed estradiol 3 beta-glucuronidation in human liver microsomes
Y Mano et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2005)
Clinical consequences of cytochrome P4502C9 polymorphisms
J Kirchheiner et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
The effect of quinidine, used as a probe for the involvement of P-glycoprotein, on the intestinal absorption and pharmacodynamics of methadone
ED Kharasch et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Characterization of the cellular localization, expression level, and function of SNP variants of MRP2/ABCC2
M Hirouchi et al.
PHARMACEUTICAL RESEARCH (2004)
Brain penetration of methadone (R)- and (S)-enantiomers is greatly increased by P-glycoprotein deficiency in the blood-brain barrier of Abcb1a gene knockout mice
JS Wang et al.
PSYCHOPHARMACOLOGY (2004)
Pharmacogenomics of the OATP and OAT families
C Marzolini et al.
PHARMACOGENOMICS (2004)
Genetic variability of μ-opioid receptor in an obstetric population
R Landau et al.
ANESTHESIOLOGY (2004)
Quinidine as a probe for the role of P-glycoprotein in the intestinal absorption and clinical effects of fentanyl
ED Kharasch et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2004)
A novel functional polymorphism in the uridine diphosphate-glucuronosyltransferase 2B7 promoter with significant impact on promoter activity
Y Duguay et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Functional characterization of four allelic variants of human cytochrome P450 1A2
HJ Zhou et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2004)
Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone
ED Kharasch et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Human UGT1A6 pharmacogenetics: identification of a novel SNP, characterization of allele frequencies and functional analysis of recombinant allozymes in human liver tissue and in cultured cells
S Nagar et al.
PHARMACOGENETICS (2004)
Anesthetic requirement is increased in redheads
EB Liem et al.
ANESTHESIOLOGY (2004)
Codeine intoxication associated with ultrarapid CYP2D6 metabolism
Y Gasche et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Interindividual variability in ibuprofen pharmacokinetics is related to interaction of cytochrome P4502C8 and 2C9 amino acid polymorphisms
E García-Martín et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
CYP2C9 genotypes and the pharmacokinetics of tenoxicam in Brazilians
R Vianna-Jorge et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Catalytic roles of CYP2C9 and its variants (CYP2C9*2 and CYP2C9*3) in lornoxicam 5 '-hydroxylation
I Iida et al.
DRUG METABOLISM AND DISPOSITION (2004)
Genetic predisposition to acute gastrointestinal bleeding after NSAIDs use
C Martinez et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Polymorphisms in human MDR1 (P-glycoprotein): Recent advances and clinical relevance
C Marzolini et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry
UM Zanger et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2004)
Pharmacokinetic-pharmacodynamic modeling of morphine-6-glucuronide-induced analgesia in healthy volunteers - Absence of sex differences
R Romberg et al.
ANESTHESIOLOGY (2004)
Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms
M Ingelman-Sundberg
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2004)
The 118 A > G polymorphism in the human μ-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease
P Klepstad et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2004)
The potential role of cyclooxygenase-2 inhibitors in the treatment of experimentally-induced mammary tumour: does celecoxib enhance the anti-tumour activity of doxorubicin?
WM Awara et al.
PHARMACOLOGICAL RESEARCH (2004)
Pharmacokinetics of dextromethorphan after single or multiple dosing in combination with quinidine in extensive and poor metabolizers
LE Pope et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19
JG Gerber et al.
CHIRALITY (2004)
Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine
ED Kharasch et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Pharmacogenetics of cytochrome P4502D6: genetic background and clinical implication
I Cascorbi
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2003)
Respiratory and miotic effects of morphine in healthy volunteers when P-glycoprotein is blocked by quinidine
C Skarke et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Isoform selectivity and kinetics of morphine 3-and 6-glucuronidation by human UDP-glucuronosyltransferases: Evidence for atypical glucuronidation kinetics by UGT2B7
AN Stone et al.
DRUG METABOLISM AND DISPOSITION (2003)
Impact of CYP2D6 genotype on postoperative tramadol analgesia
UM Stamer et al.
PAIN (2003)
Evaluation of 3′-azido-3′-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes:: Specificity and influence of the UGT2B7*2 polymorphism
MH Court et al.
DRUG METABOLISM AND DISPOSITION (2003)
A genetic association study of the mu opioid receptor and severe opioid dependence
JJ Crowley et al.
PSYCHIATRIC GENETICS (2003)
The metabolism of diclofenac - Enzymology and toxicology perspectives
W Tang
CURRENT DRUG METABOLISM (2003)
A discordance between cytochrome P450 2D6 genotype and phenotype in patients undergoing methadone maintenance treatment
MR Shiran et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Rapid assessment of P-glycoprotein inhibition and induction in vitro
MD Perloff et al.
PHARMACEUTICAL RESEARCH (2003)
Influence of CYP2C9 genetic polymorphisms on pharmacokinetics of celecoxib and its metabolites
J Kirchheiner et al.
PHARMACOGENETICS (2003)
Adverse drug reactions to oxycodone and hydrocodone in CYP2D6 ultrarapid metabolizers
J de Leon et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2003)
CYP2C9 genotypes and diclofenac metabolism in Spanish healthy volunteers
P Dorado et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Interaction of buprenorphine and its metabolite norbuprenorphine with cytochromes P450 in vitro
WJ Zhang et al.
DRUG METABOLISM AND DISPOSITION (2003)
A pharmacogenetic study of uridine diphosphate-glucuronosyltransferase 2B7 in patients receiving morphine
MB Sawyer et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
The melanocortin-1 receptor gene mediates female-specific mechanisms of analgesia in mice and humans
JS Mogil et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Differences in flurbiprofen pharmacokinetics between CYP2C9*1/*1, *1/*2, and *1/*3 genotypes
CR Lee et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Isozyme-specific induction of low-dose aspirin on cytochrome P450 in healthy subjects
XP Chen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
COMT val158met genotype affects μ-opioid neurotransmitter responses to a pain stressor
JK Zubieta et al.
SCIENCE (2003)
Pharmacokinetics of diclofenac and inhibition of cyclooxygenases 1 and 2: no relationship to the CYP2C9 genetic polymorphism in humans
J Kirchheiner et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteers
C Skarke et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Genetic variation in cyclooxygenase 1: Effects on response to aspirin
MK Halushka et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients
M Holthe et al.
PHARMACOGENOMICS JOURNAL (2003)
Pharmacokinetic interactions with rifampicin - Clinical relevance
M Niemi et al.
CLINICAL PHARMACOKINETICS (2003)
Strategies and molecular probes to investigate the role of cytochrome P450 in drug metabolism - Focus on in vitro studies
MT Donato et al.
CLINICAL PHARMACOKINETICS (2003)
Influence of age and cytochrome P4502C9 genotype on the steady-state disposition of diclofenac and celecoxib
SS Brenner et al.
CLINICAL PHARMACOKINETICS (2003)
Pharmacogenetics of codeine metabolism in an urban population of children and its implications for analgesic reliability
DG Williams et al.
BRITISH JOURNAL OF ANAESTHESIA (2002)
Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine
I Meineke et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms
U Yasar et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Genetic contribution to variable human CYP3A-mediated metabolism
JK Lamba et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene
A Johne et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy
M Holthe et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Enantiospecific effects of cytochrome P4502C9 amino acid variants on ibuprofen pharmacokinetics and on the inhibition of cyclooxygenases 1 and 2
J Kirchheiner et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
The antinociceptive effect of tramadol in the formalin test is mediated by the serotonergic component
P Oliva et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Ondansetron inhibits the analgesic effects of tramadol:: A possible 5-HT3 spinal receptor involvement in acute pain in humans
R Arcioni et al.
ANESTHESIA AND ANALGESIA (2002)
Inhibition of human drug metabolizing cytochrome P450 by buprenorphine
K Umehara et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2002)
Interaction of morphine, fentanyl, sufentanil, affientanil, and loperamide with the efflux drug transporter p-glycoprotein
C Wandel et al.
ANESTHESIOLOGY (2002)
Cytochrome P4502C9 polymorphisms: a comprehensive review of the in-vitro and human data
CR Lee et al.
PHARMACOGENETICS (2002)
Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study
J Fellay et al.
LANCET (2002)
Interindividual variability of the clinical pharmacokinetics of methadone - Implications for the treatment of opioid dependence
CB Eap et al.
CLINICAL PHARMACOKINETICS (2002)
Clinical significance of the cytochrome P4502C19 genetic polymorphism
Z Desta et al.
CLINICAL PHARMACOKINETICS (2002)
The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine
J Lotsch et al.
PHARMACOGENETICS (2002)
The genetic determinants of the CYP3A5 polymorphism
E Hustert et al.
PHARMACOGENETICS (2001)
MDR1 P-glycoprotein transports endogenous opioid peptides
RPJO Elferink et al.
PEPTIDES (2001)
Clinical implications of drug interactions with coxibs
WR Garnett
PHARMACOTHERAPY (2001)
Identification and functional characterization of α2-adrenoceptor polymorphisms
KM Small et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2001)
The pharmacogenetics of analgesia: toward a genetically-based approach to pain management
CM Flores et al.
PHARMACOGENOMICS (2001)
Contribution of dihydrocodeine and dihydromorphine to analgesia following dihydrocodeine administration in man: a PK-PD modelling analysis
JA Webb et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Is cytochrome P4502C9 genotype associated with NSAID gastric ulceration?
JH Martin et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
In-vitro metabolism of celecoxib, a cyclooxygenase-2 inhibitor, by allelic variant forms of human liver microsomal cytochrome P4502C9:: correlation with CYP2C9 genotype and in-vivo pharmacokinetics
CY Tang et al.
PHARMACOGENETICS (2001)
ABC transporters: physiology, structure and mechanism - an overview
CF Higgins
RESEARCH IN MICROBIOLOGY (2001)
Cytochrome P450 2D6 genotype and methadone steady-state concentrations
CB Eap et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2001)
Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs
M King et al.
NATURE NEUROSCIENCE (2001)
Methadone, ciprofloxacin, and adverse drug reactions
K Herrlin et al.
LANCET (2000)
Interaction between methotrexate and nonsteroidal anti-inflammatory drugs in organic anion transporter
Y Uwai et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Sequence variability and candidate gene analysis in complex disease:: association of μ opioid receptor gene variation with substance dependence
MR Hoehe et al.
HUMAN MOLECULAR GENETICS (2000)
Pindolol, a beta-adrenoceptor blocker/5-hydroxytryptamine1A/1B antagonist, enhances the analgesic effect of tramadol
MO Rojas-Corrales et al.
PAIN (2000)
Relationship of polymorphism in CYP2C9 to genetic susceptibility to diclofenac-induced hepatitis
GP Aithal et al.
PHARMACOGENETICS (2000)
Opiate-induced analgesia is increased and prolonged in mice lacking P-glycoprotein
SJ Thompson et al.
ANESTHESIOLOGY (2000)
Functional polymorphisms of the human multidrug-resistance gene:: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo
S Hoffmeyer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation
PT Manyike et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Increased drug delivery to the brain by P-glycoprotein inhibition
AJM Sadeque et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
CYP2C9 Ile(359) and Leu(359) variants: enzyme kinetic study with seven substrates
K Takanashi et al.
PHARMACOGENETICS (2000)
分享论文
